Novartis Q3 EPS beats by $0.22 and raises 2026 core operating income outlook
FROM THE WIRE · SEEKINGALPHA.COM
Novartis Q3 earnings beat EPS estimates, missed revenue, and raised 2026 core operating income guidance.
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishA guidance raise from a mega-cap pharma company can move the healthcare sector and the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Novartis reported Q3 non-GAAP EPS of $2.46, beating estimates by $0.22.
- 02Revenue missed expectations in the quarter.
- 03The company raised its 2026 core operating income guidance.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets